Back to News
Market Impact: 0.32
Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology
Source: PR Newswire
Healthcare & BiotechArtificial IntelligenceTechnology & Innovation
Earendil Labs announced a research collaboration with Genentech, part of Roche Group, to discover and develop multiple therapeutic bispecific antibodies. The deal validates Earendil's AI-powered biologics platform and could expand its drug-development pipeline, though no financial terms, program targets, or timelines were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
More News
- MRK's 2027 Outlook Challenging, Long-Term Prospects Promising
- Nasdaq defies Nvidia impact as Huang faces espionage affair probe
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Nvidia's CEO turmoil gives newly empowered Democrats fresh ammunition in pursuit of oversight
- Key AI chip index just broke its long-term trendline. What history says happens next
- Banks, investors grow wary of AI debt, spooked by market selloff